News
From Lab to Field: Progress in Crimean-Congo Haemorrhagic Fever Testing
In the ongoing fight against Crimean-Congo Haemorrhagic Fever (CCHF), Global Access Diagnostics (GADx) has joined forces with the Liverpool School of Tropical Medicine and international experts to develop a rapid diagnostic test (RDT) tailored for…
Innovating Epidemic Surveillance: GADx partners on HOLICARE
GADx, in partnership with an international consortium, is revolutionising healthcare in low- and middle-income countries through the HOLICARE project. HOLICARE is a groundbreaking initiative established to improve the diagnosis of respiratory tract infections (RTIs), addressing…
New CEO at GADx, Dr Mark Street-Docherty
It is with great pleasure that Mologic Ltd t/a Global Access Diagnostics (GADx), announces the appointment of our new CEO, starting 1st February 2024, Dr Mark Street-Docherty. Mark brings with him enormous experience of leading…